New therapeutic approaches to autoimmune disease.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D002460:Cell Line; D003524:Cyclosporins / Q000627:therapeutic use; D004032:Diet; D005260:Female; D012739:Gonadal Steroid Hormones / Q000008:administration & dosage / Q000276:immunology / Q000502:physiology / Q000627:therapeutic use; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007116:Immunization, Passive; D007165:Immunosuppression Therapy / Q000379:methods; D007542:Inosine Pranobex / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D008212:Lymphocyte Depletion; D008221:Lymphoid Tissue / Q000528:radiation effects; D008297:Male; D051379:Mice; D013601:T-Lymphocytes / Q000276:immunology / Q000637:transplantation
D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D012739:Gonadal Steroid Hormones; D006680:HLA Antigens; D007978:Levamisole; D007542:Inosine Pranobex